News

Find News

Filter articles

Applied Filters

Showing 51 to 60 of 946 results

Mylan launches Tecfidera generic amid Biogen battle

US20-08-2020Sarah Morgan

Mylan launched its generic version of Biogen’s $4 billion-a-year multiple sclerosis drug Tecfidera yesterday, August 19.

FDA approves Dr Reddy’s Vascepa generic

US13-08-2020Rory O'Neill

Indian drugmaker Dr Reddy’s has won approval to launch just the second generic version of heart drug Vascepa, in another blow for Amarin.

Teva sues Cipla over generic asthma inhalers

11-08-2020Rory O'Neill

Israeli drug manufacturer Teva Pharmaceuticals is suing India-based Cipla to block the launch of generic Qvar asthma inhalers.

BMS, Pfizer secure victory over generic makers

US07-08-2020Sarah Morgan

In a victory for Bristol-Myers Squibb and Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis.

Humira buyers appeal AbbVie ruling to Seventh Circuit

US31-07-2020Sarah Morgan

Buyers of AbbVie’s arthritis treatment Humira have appealed against an Illinois judge’s decision to dismiss their class action antitrust suit to the US Court of Appeals for the Seventh Circuit.

Ninth Circuit affirms California’s pay-for-delay ban

US27-07-2020Rory O'Neill

A US federal appeals court has refused to block California’s ban on pay-for-delay deals in the generic drugs industry.

Sun Pharma to pay $205m over generics price-fixing

24-07-2020Rory O'Neill

A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.

CJEU ‘shuts door’ on SPCs for second medical uses

EU10-07-2020Rory O'Neill

The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.

Australian court affirms Mylan patent invalidation

Australia06-07-2020

The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.

Sandoz fails in Enbrel patent challenge, but Fed Circuit split

US02-07-2020Rory O'Neill

Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.

Showing 51 to 60 of 946 results

LSIPR